Tuesday, January 27, 2015

MagForce AG and MagForce USA, Inc. Announce FDA Pre-IDE Meeting on MagForce's NanoTherm(TM) Prostate Cancer Therapy Pre-Submission

… MagForce's NanoTherm(TM) Prostate Cancer Therapy Pre-Submission MagForce AG (Frankfurt … focally ablate prostate cancer. MagForce USA, Inc. will accelerate the prostate cancer Investigational Device … the targeted treatment of solid tumors through the intratumoral generation of …

No comments:

Post a Comment